J&T Ventures and Lead Ventures have invested €6 million in health tech scale-up Xund to enhance digital healthcare interactions and insights.

Target Company Overview

Xund is an innovative health tech company specializing in digital solutions that enable healthcare providers to enhance their interactions with patients. The company focuses on transforming data into actionable insights, thereby improving efficiency and patient care. With a firm commitment to leveraging technology for better healthcare outcomes, Xund aims to streamline healthcare processes and contribute significantly to the evolving medical landscape.

Founded with the intent to bridge the gap between healthcare and technology, Xund has rapidly established itself as a critical player in this sector, offering a range of solutions designed to simplify healthcare management.

Industry Overview in the Czech Republic

The healthcare industry in the Czech Republic is undergoing significant transformation, driven by digitalization and technological advancements. As the country strives to modernize its healthcare system, there is a strong emphas

View Source

Similar Deals

Unknown Aeon

2025

Other VC Medical & Diagnostic Laboratories Other
GOCA3 Technologie de mesure de fluidité membranaire

2025

Other VC Bio Diagnostics & Testing Other
Avadel Pharmaceuticals plc XWPharma Ltd.

2025

Other VC Proprietary & Advanced Pharmaceuticals Other
Biostate AI Biostate AI

2025

Other VC Biotechnology & Medical Research (NEC) Other
NTT DOCOMO Ventures Total Future Healthcare Inc.

2025

Other VC Telemedicine Services Other
Innovate Capital EMSCO Scientific Enterprise, Inc.

2024

Other VC Biotechnology & Medical Research (NEC) Other

J&T Ventures and Lead Ventures

invested in

Xund

in 2024

in a Other VC deal

Disclosed details

Transaction Size: $6M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert